Concurrent Neoadjuvant Chemoradiotherapy for Siewert II and III Adenocarcinoma at Gastroesophageal Junction - Wikidata - wikimedia - TriplyDB

Concurrent Neoadjuvant Chemoradiotherapy for Siewert II and III Adenocarcinoma at Gastroesophageal Junction

Concurrent Neoadjuvant Chemoradiotherapy for Siewert II and III Adenocarcinoma at Gastroesophageal Junction

http://www.wikidata.org/entity/Q33422992

about

QKI5-mediated alternative splicing of the histone variant macroH2A1 regulates gastric carcinogenesis.

P2860

Q37362779-3174CA7E-D1E1-48FC-AC6C-59B9081E19F5

P2860

Concurrent Neoadjuvant Chemoradiotherapy for Siewert II and III Adenocarcinoma at Gastroesophageal Junction

http://www.wikidata.org/entity/Q33422992

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Concurrent Neoadjuvant Chemora ...... a at Gastroesophageal Junction

@ast

Concurrent Neoadjuvant Chemora ...... a at Gastroesophageal Junction

@en

type

label

Concurrent Neoadjuvant Chemora ...... a at Gastroesophageal Junction

@ast

Concurrent Neoadjuvant Chemora ...... a at Gastroesophageal Junction

@en

prefLabel

Concurrent Neoadjuvant Chemora ...... a at Gastroesophageal Junction

@ast

Concurrent Neoadjuvant Chemora ...... a at Gastroesophageal Junction

@en

P1433

Q33422992-9B73B8CE-7C97-464D-A7B7-FF6E3EF75D74

P1476

Q33422992-EEE24F2B-67F0-477E-AC1F-4B31C8C8CCB4

P2093

Q33422992-06B60F9D-43FD-4993-B4C7-8137A0904A4D

Q33422992-17DE883E-B22A-40D5-AA4A-CC081C95A07F

Q33422992-372B1808-FC17-45A9-8A88-637EA6F3CA93

Q33422992-4339ED30-6CEA-49DA-87F1-37F0ADE87342

Q33422992-789AE8BC-79CC-4E9B-9708-8135D65A8D70

Q33422992-A2692485-1E60-4E4B-8A9F-EDD3C31B8488

Q33422992-B1204A97-0019-48BF-A3E5-D41B2C08D236

Q33422992-BB2E91A3-EED7-4415-B1EF-52240D254B33

Q33422992-CC2089BC-3E95-4E50-94D9-11A992932A74

Q33422992-D3AD1126-5E20-4F74-B182-C546A4E46C77

P2860

Q33422992-02F7270A-4E4A-4E61-8D07-3FC7C7475137

Q33422992-14A6C155-83B1-450F-8709-D62EE9C915DF

Q33422992-1E0C8D6B-58C9-481E-9BE0-334C1D9D69C8

Q33422992-281D9178-2EB3-4E59-B3E7-AFF05EC53963

Q33422992-40979CAE-578E-4BEA-BA9C-F37742C19E6E

Q33422992-44CEABB8-680A-428A-84BE-9D5EEC42A703

Q33422992-4EBB12D2-61C9-45C1-A504-1624062658CE

Q33422992-555DDDC6-0396-4219-B576-BE84DE2E28F3

Q33422992-58087C6F-7B9B-4708-B389-F845AE409AC1

Q33422992-718E0316-0B86-4AC4-96FC-160E242C040E

P304

Q33422992-A0652917-6D07-4132-AEB8-63BF4352B8F2

P31

Q33422992-EF8796DA-1562-4B76-85C6-8BC9E99F60B5

P356

Q33422992-3265AB8A-15A6-4086-9022-6890EBF4EC7C

P407

Q33422992-5C17A8C3-8502-41B2-A2E3-5BB215AF5D5A

P433

Q33422992-DE72AC12-510F-49C8-8F6A-BC49B4E9AF17

P478

Q33422992-2BB37B99-71DB-42DA-AC29-EA626BBD6711

P577

Q33422992-091A6CAE-782E-4B7B-B175-61D8DFDCA159

P5875

Q33422992-0427D9DF-FF96-4DE9-804E-C4EE56AE2FE9

P698

Q33422992-90645F11-C058-4D3D-AD3A-960BD2248947

P921

Q33422992-049057D3-AFE0-4D3B-9F49-64402A14B9E0

P932

Q33422992-5A89E6F9-E94F-4F40-8FBB-487907490803

P356

MAJ.0000000000000476

P1433

American Journal of the Medical Sciences

P1476

Concurrent Neoadjuvant Chemora ...... a at Gastroesophageal Junction

@en

P2093

Bibo Tan

http://www.w3.org/2001/XMLSchema#string

Gaofeng Shi

http://www.w3.org/2001/XMLSchema#string

Jun Wang

http://www.w3.org/2001/XMLSchema#string

Jun Zhang

http://www.w3.org/2001/XMLSchema#string

Peigang Yang

http://www.w3.org/2001/XMLSchema#string

Qian Xu

http://www.w3.org/2001/XMLSchema#string

Qun Zhao

http://www.w3.org/2001/XMLSchema#string

Ruxun Li

http://www.w3.org/2001/XMLSchema#string

Xueying Qiao

http://www.w3.org/2001/XMLSchema#string

Yong Li

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical management of gastroesophageal junction tumors: past and recent evidences for the role of radiotherapy in the multidisciplinary approach

Epidemiology and risk factors for gastroesophageal junction tumors: understanding the rising incidence of this disease

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

Preoperative chemo(radio)therapy versus primary surgery for gastroesophageal adenocarcinoma: systematic review with meta-analysis combining individual patient and aggregate data.

Phase II study of oxaliplatin plus S-1 as first-line treatment for advanced gastric cancer (G-SOX study).

Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Cancer Staging Manuals.

Radiotherapy for tumors of the stomach and gastroesophageal junction--a review of its role in multimodal therapy.

Prospective, open, multi-centre phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and oxaliplatin in patients with adenocarcinoma of the oesophagogastric junction.

Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial.

P304

472-476

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MAJ.0000000000000476

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

349

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277082432

http://www.w3.org/2001/XMLSchema#string

P698

25996101

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

P932

4450970

http://www.w3.org/2001/XMLSchema#string